A DISEASE-RELATED RHEUMATOID-FACTOR AUTOANTIBODY IS NOT TOLERIZED IN A NORMAL MOUSE - IMPLICATIONS FOR THE ORIGINS OF AUTOANTIBODIES IN AUTOIMMUNE-DISEASE
Lg. Hannum et al., A DISEASE-RELATED RHEUMATOID-FACTOR AUTOANTIBODY IS NOT TOLERIZED IN A NORMAL MOUSE - IMPLICATIONS FOR THE ORIGINS OF AUTOANTIBODIES IN AUTOIMMUNE-DISEASE, The Journal of experimental medicine, 184(4), 1996, pp. 1269-1278
We have analyzed B cell tolerance in a rheumatoid factor (RF) transgen
ic mouse model. The model is based on AM14, a hybridoma originally iso
lated from an autoimmune MRL/lpr mouse that has an affinity and specif
icity typical of disease-related RFs from this strain, AM14 binds to i
mmunoglobulin (Ig)G2a of the ''a'' allotype (IgG2a(a)) and not to IgG2
a(b). Thus, by crossing the transgenes onto an IgH(a) (BALB/c) backgro
und or to a congenic IgH(b) (CB.17) background, we could study the RF-
expressing B cells when they were self-specific-(IgH(a)) or when they
were not self-specific (IgH(b)). These features make the AM14 model un
ique in focusing on a true autoantibody specificity while at the same
time allowing comparison of autoreactive and nonautoreactive transgeni
c B cells, as was possible in model autoantibody systems such as anti-
hen egg lysozyme. Studies showed that AM14 RF B cells can make primary
immune responses and do not downregulate sIgM, indicating that the pr
esence of self-antigen does not induce anergy of these cells. In fact,
IgH(a) AM14 transgenic mice have higher serum levels of transgene-enc
oded RF than their IgH(b) counterparts, suggesting that self-antigen-s
pecific activation occurs even in the normal mouse background. Since A
M14 B cells made primary responses, we had the opportunity to test for
potential blocks to self-reactive cells entering the memory compartme
nt. We did not find evidence of this, as AM14 B cells made secondary i
mmune responses as well. These data demonstrate that a precursor of a
disease-specific autoantibody can be present in the preimmune repertoi
re and functional even to the point of memory cell development of norm
al mice. Therefore, immunoregulatory mechanisms that normally prevent
autoantibody production must exert their effects later in B cell devel
opment or through T cell tolerance. Conversely, the data suggest that
it is not necessary to break central tolerance, even in an autoimmune
mouse, to generate pathologic, disease-associated autoantibodies.